Alaska Senator Lisa Murkowski continues crusade against genetically engineered salmon in US

CphtX DUEAA QD

Controversial genetically engineered (GE) salmon pioneer AquaBounty Technologies could be cleared to begin US salmon sales if a continued prohibition against its imports isn’t inserted into the next federal budget, the company says.

However, an Alaskan senator who was crucial in tweaking a 2016 budget bill that led to the import ban says that she will continue to fight for the company’s salmon to be labeled as genetically engineered ahead of any US sales.

When contacted, Karina Petersen, a spokeswoman for the office of Alaska Senator Lisa Murkowski, who fought for the import ban, told Undercurrent News that efforts to continue blocking AquaBounty’s efforts to get the fish to market in the US are ongoing.

“Senator Murkowski is working to ensure that production will not happen until labeling guidelines are in place and there is a proper review of the process by which GE salmon and future GE animals for human consumption are approved,” Petersen said. “Omnibus spending bill negotiations are currently underway.”

Murkowski has been a leader in the legislature militating against GE salmon sales in the US. After the FDA granted its approval to the company in 2015, the senator has switched her focus to requiring labeling for GE animals.

Read full, original post: One hurdle for AquaBounty could go, but others remain

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.